University of Leicester
Browse
IndianJMedRes125110-2473217_065212.pdf (51.82 kB)

Elevation of tumour marker CA-125 in serum & body fluids: interpret with caution

Download (51.82 kB)
journal contribution
posted on 2016-04-14, 10:59 authored by Syed Fayyaz Hussain, P. Camilleri
First paragraph: The cancer antigen (CA) -125 is a high molecular mass glycoprotein produced both by ovarian cancer cells as also by normal cells of tissues derived from coelomic epithelium. Serum CA-125 levels are used as a marker of tumour activity in patients known to have ovarian carcinoma1 and commercial tests for serum CA-125 have been available since 1983. In women with histologically proven ovarian carcinoma, levels of serum CA-125 are elevated >35 U/ml in more than 80 per cent of cases. Levels are also measured after debulking surgery and during chemotherapy.

History

Citation

Indian Journal of Medical Research 125, January 2007, pp 10-12

Version

  • VoR (Version of Record)

Published in

Indian Journal of Medical Research 125

Publisher

Medknow Publications for Indian Council of Medical Research (ICMR)

issn

0971-5916

Available date

2016-04-14

Publisher version

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2007;volume=125;issue=1;spage=10;epage=12;aulast=Hussain;type=0

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC